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httpIntroduction: Intravenous leiomyomatosis is a rare, life-threatening intravenous tumor associated with uterine
leiomyomata.
Report: This report describes the case of a 45-year-old woman with a history of weakness and exertional
dyspnea, and an extensive intracaval mass extending to the right side of the heart. The tumor was successfully
removed in a two-stage surgical procedure with an inferior vena cava (IVC) ﬁlter deployed before the second
stage. An extensive DVT was observed postoperatively.
Discussion: Surgical removal is the only effective treatment for intravenous leiomyomatosis, and the rate of
recurrence remains unclear. An IVC ﬁlter should be placed routinely to prevent postoperative or late (in case of
recurrence) pulmonary embolism.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Intravenous leiomyomatosis (IVL) is a rare condition asso-
ciated with uterine leiomyomata. It consists of the benign
proliferation of smooth muscle cells, starting at the uterine
or gonadal veins, extending to the venous drainage system
of the abdomen and pelvis, and potentially reaching the
right heart and the pulmonary arteries. Although the tumor
is nonmalignant, the obstruction to ﬂow can lead to severe
cardiopulmonary complications and death.
CASE REPORT
A 45-year-old woman presented with a 3-week history of
weakness and exertional dyspnea. Transthoracic echocardi-
ography revealed a large, free-ﬂoating mass in the cham-
bers of the right side of the heart.
Computed tomography (CT) scan conﬁrmed those ﬁnd-
ings, showing a thrombus-like hypodense mass
(4.5  3.0 cm) in the right atrium extending to the right
ventricle and involving the inferior vena cava (IVC) and both
iliac veins. The renal veins were free, and pulmonary em-
bolism (PE) was excluded. Transesophageal echocardiogra-
phy excluded structural or functional changes of the heart
(Fig. 1A).
The patient was submitted to a two-stage surgical pro-
cedure, ﬁrst through a median sternotomy,of original article: http://dx.doi.org/10.1016/j.ejvs.2014.05.009
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removal of the atrial tumor, and partial resection of the IVC
mass was performed. The patient’s recovery was
uneventful.
Histology and immunohistochemical studies were
compatible with uterine leiomyoma, and the diagnosis of
IVL was established.
At the second stage, 7 weeks later, a laparotomy was
performed for total hysterectomy, left salpingo-
oopherectomy, and right salpingectomy. Additionally, the
tumor was removed from the IVC and iliac veins, and a
TRAPEASE IVC ﬁlter (Cordis; Johnson & Johnson, New
Brunswick, NJ, USA) was deployed (Fig. 1B).
Histology conﬁrmed uterine ﬁbroleiomyomas similar to
those previously removed from the heart.
Postoperative recovery was complicated by iliocaval deep
vein thrombosis (DVT) below the IVC ﬁlter 3 weeks later.
The patient presented with lower limb edema while un-
dergoing prophylactic anticoagulation. This was treated
successfully with therapeutic oral anticoagulation. (Fig. 1C).
At the 24-month follow-up the patient remained
asymptomatic with no evidence of recurrent disease and
showing recanalization of the thrombus on CT scanning.DISCUSSION
IVL was ﬁrst described in 1896 by Birch-Hirschfeld and later
deﬁned as a rare uterine neoplasm characterized by nodular
masses of histologically benign smooth muscle growing
within veins as worm-like projections.1e3
The etiology remains unclear and the clinical presenta-
tion varies widely.1,4,5 Patients can be asymptomatic or
Figure 1. (A) Transesophageal echocardiography showing the intracardiac tumor in the right atrium. (B) Surgical specimen removed from
the inferior vena cava (IVC) and iliac veins during the second procedure. (C) Computed tomography showing recanalization of the
thrombus trapped in the IVC ﬁlter 4 months after the iliocaval deep vein thrombosis.
e44 I. Ferraz de Oliveira et al.present with uterine leiomyoma without signs of venous
invasion. Venous involvement can be a major problem,
leading to complications such as BuddeChiari syndrome,
PE, outﬂow obstruction of the right side of the heart, heart
failure, or even death.1
Surgical removal is the only effective treatment.
Currently, there are two main surgical approaches for IVL
with intracardiac extension: a one- or two-stage procedure.2
Given the patient’s condition in this case, a two-stage
approach, which is a less invasive and makes for a quicker
recovery, was selected.
During the ﬁrst stage, the intracardiac portion and part of
the intracaval tumor are extracted through a median ster-
notomy. Depending on the patient’s recovery, the second
stage is performed via laparotomy as soon as possible. This
stage includes the removal of the tumor form the IVC and
the iliac veins, as well as hysterectomy and salpingo-
oopherectomy.2
In this case, a decision to deploy an IVC ﬁlter was taken
after completion of the second stage procedure in order to
prevent postoperative PEda decision considered to be
appropriate owing to extensive DVT proximal to the IVC
ﬁlter.
Much controversy has been raised concerning the ideal
time for deployment of the ﬁlter. Some have defended
retrograde placement, acting during the cardiac surgical
procedure, as described by Barskdale et al.3 Others have
argued that the ideal time comes after completion of the
second operation. This was what was performed in this
case. However, whatever the option selected, the place-
ment of an IVC ﬁlter seems to be required because of the
high risk of DVT and PE associated with IVL resection.Patients submitted to IVL resection extending to the IVC
should have an IVC ﬁlter to prevent PE associated with
venous thrombosis. IVL carries a risk of recurrence, and is
unpredictable owing to it slow growth rate.4 Patients with
this condition should therefore be maintained under long-
term clinical, ultrasound, and CT surveillance.FUNDING
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